BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15887016)

  • 1. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
    Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
    Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
    Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
    Salloum RM; Jaskowiak NT; Mauceri HJ; Seetharam S; Beckett MA; Koons AM; Hari DM; Gupta VK; Reimer C; Kalluri R; Posner MC; Hellman S; Kufe DW; Weichselbaum RR
    Cancer Res; 2000 Dec; 60(24):6958-63. PubMed ID: 11156396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
    Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
    Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxycycline potentiates antitumor effect of cyclophosphamide in mice.
    Chhipa RR; Singh S; Surve SV; Vijayakumar MV; Bhat MK
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):268-77. PubMed ID: 15667832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
    Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
    Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
    Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor model.
    Ishida T; Shiraga E; Kiwada H
    J Control Release; 2009 Mar; 134(3):194-200. PubMed ID: 19095022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.
    Lee WT; Tamai H; Cohen P; Teker AM; Shu S
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):608-13. PubMed ID: 18559727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined millimeter wave and cyclophosphamide therapy of an experimental murine melanoma.
    Logani MK; Bhanushali A; Anga A; Majmundar A; Szabo I; Ziskin MC
    Bioelectromagnetics; 2004 Oct; 25(7):516-23. PubMed ID: 15376243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial wires releasing diffusing alpha emitters combined with chemotherapy improved local tumor control and survival in squamous cell carcinoma-bearing mice.
    Cooks T; Arazi L; Efrati M; Schmidt M; Marshak G; Kelson I; Keisari Y
    Cancer; 2009 Apr; 115(8):1791-801. PubMed ID: 19197995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
    Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
    Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.